Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer.
Read More

DeNovix Inc., will donate a limited edition Pink CellDrop Automated Cell Counter to one lucky research lab. The winner, randomly chosen from entries to the company’s drawing, will be announced following the conclusion of the annual AACR meeting being held in San Diego, CA. April 24th – 29th, 2020.
Read More

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.
Read More

Researchers at CHU Sainte-Justine and Université de Montréal have discovered a new mechanism involved in the expression of Down syndrome, one of the main causes of intellectual disability and congenital heart defects in children.
Read More

Research into engineering artificial organs that mimic the functions of human lymph nodes at The University of Alabama in Huntsville has garnered one of its professors a $507,777 National Science Foundation Faculty Early Career Development Program Award.
Read More

The Biophotonics Imaging Lab at the Beckman Institute for Advanced Science and Technology has developed imaging techniques that investigate tissues without using any staining or labels.
Read More

The 7th annual Metastatic Breast Cancer Research Conference will be hosted by Huntsman Cancer Institute at the University of Utah in partnership with Baylor College of Medicine and Theresa’s Research Foundation on September 10 and 11, 2020.
Read More

We’ve all feared hearing a doctor say, “We need to talk.” It’s even scarier if the physician is robotic, speaks in jargon or isn’t clear about next steps.
Read More

Ultraviolet technology developed by the New York-based firm PurpleSun Inc. eliminates more than 96 percent of pathogens in operating rooms and on medical equipment, compared to 38 percent using manual cleaning methods that rely on chemicals to disinfect surfaces, according to a study published this month in the American Journal of Infection Control.
Read More

After 50 years of research and the testing of over 1,000 drugs, there is new hope for preserving brain cells for a time after stroke.
Read More